Cargando…
Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV
Visceral leishmaniasis (VL) has emerged as a clinically important opportunistic infection in HIV patients, as VL/HIV co-infected patients suffer from frequent VL relapse. Here, we follow cohorts of VL patients with or without HIV in Ethiopia. By the end of the study, 78.1% of VL/HIV—but none of the...
Autores principales: | Takele, Yegnasew, Mulaw, Tadele, Adem, Emebet, Shaw, Caroline Jayne, Franssen, Susanne Ursula, Womersley, Rebecca, Kaforou, Myrsini, Taylor, Graham Philip, Levin, Michael, Müller, Ingrid, Cotton, James Anthony, Kropf, Pascale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784791/ https://www.ncbi.nlm.nih.gov/pubmed/35106507 http://dx.doi.org/10.1016/j.xcrm.2021.100487 |
Ejemplares similares
-
Recurrent visceral leishmaniasis relapses in HIV co-infected patients are characterized by less efficient immune responses and higher parasite load
por: Takele, Yegnasew, et al.
Publicado: (2022) -
Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation
por: Takele, Yegnasew, et al.
Publicado: (2022) -
Following successful anti-leishmanial treatment, neutrophil counts, CD10 expression and phagocytic capacity remain reduced in visceral leishmaniasis patients co-infected with HIV
por: Takele, Yegnasew, et al.
Publicado: (2022) -
Diversity and Within-Host Evolution of Leishmania donovani from Visceral Leishmaniasis Patients with and without HIV Coinfection in Northern Ethiopia
por: Franssen, Susanne U., et al.
Publicado: (2021) -
Successful Treatment of Human Visceral Leishmaniasis Restores Antigen-Specific IFN-γ, but not IL-10 Production
por: Adem, Emebet, et al.
Publicado: (2016)